about
Compartmentalization of androgen receptor protein-protein interactions in living cellsFluorescence resonance energy transfer of GFP and YFP by spectral imaging and quantitative acceptor photobleaching.Functional analysis of novel androgen receptor mutations in a unique cohort of Indonesian patients with a disorder of sex development.The divergent effects of tumour necrosis factor-alpha on skeletal muscle: implications in wasting.The Effect of F877L and T878A Mutations on Androgen Receptor Response to Enzalutamide.Quantitation of glucocorticoid receptor DNA-binding dynamics by single-molecule microscopy and FRAPAutomated spherical aberration correction in scanning confocal microscopy.Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.Structure of the homodimeric androgen receptor ligand-binding domainAndrogen receptor coregulators: recruitment via the coactivator binding groove.Three-dimensional microscopic analysis of clinical prostate specimens.The Non-Coding Transcriptome of Prostate Cancer: Implications for Clinical Practice.A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.Novel Nor-Homo- and Spiro-Oxetan- Steroids Target the Human Androgen Receptor and Act as Antiandrogens.Androgen receptor complexes probe DNA for recognition sequences by short random interactions.Cross-resistance between taxanes and new hormonal agents abiraterone and enzalutamide may affect drug sequence choices in metastatic castration-resistant prostate cancer.A multi-parameter imaging assay identifies different stages of ligand-induced androgen receptor activation.Insulator speckles associated with long-distance chromatin contactsA novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation.Increased uncoupling protein-2 gene expression in brain of lipopolysaccharide-injected mice: role of tumour necrosis factor-alpha?BRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cellsBRCA2 diffuses as oligomeric clusters with RAD51 and changes mobility after DNA damage in live cells.Multiple object tracking in molecular bioimaging by Rao-Blackwellized marginal particle filtering.Fluorescence recovery after photobleaching (FRAP) to study nuclear protein dynamics in living cells.Analysis of biomolecular dynamics by FRAP and computer simulation.Secreted Phospholipases A2 Are Intestinal Stem Cell Niche Factors with Distinct Roles in Homeostasis, Inflammation, and Cancer.TRiC controls transcription resumption after UV damage by regulating Cockayne syndrome protein A.Lack of effect of the cytokine suppressive agent FR167653 on tumour growth and cachexia in rats bearing the Yoshida AH-130 ascites hepatomaDNA Fragmentation Occurs in Skeletal Muscle during Tumor Growth: A Link with Cancer Cachexia?Extracellular Vesicle Quantification and Characterization: Common Methods and Emerging ApproachesNovel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domainStepwise androgen receptor dimerizationDeregulated microRNAs in neurofibromatosis type 1 derived malignant peripheral nerve sheath tumorsThree-dimensional architecture of common benign and precancerous prostate epithelial lesionsUptake and subcellular distribution of radiolabeled polymersomes for radiotherapy
P50
Q24683283-3E0B1F74-BFA6-4B95-B817-305BC195944DQ33352987-07408EE4-B523-4517-91E9-56C911FF8BC3Q33511940-528B0A5D-C336-447E-AD97-4C532C5EA8EDQ34110209-5E7B01A8-E3E2-4B0D-A9FA-FDC7602C5EB2Q34527336-1AD745FB-C943-4CF9-B3E7-A611E574E209Q35121856-F6939158-AE90-4EE7-841E-E4D80AC53D4CQ35537016-398ABCC5-699A-417E-9DDE-D9DF7DFBCD7FQ35829605-2CCBFC27-FAEE-42C5-936F-88A41C5A97D9Q37637859-42A30628-3D9F-47FB-B021-AE60FE9DE049Q37922884-8891BB5C-2442-4C9F-A012-FA17B1E15480Q38379538-D4D4E0DD-E2C0-4479-8B0D-C000A105C9D5Q38744451-392461EC-F02B-4DA0-B90E-64D3359DA9B0Q38958176-92A8793A-E792-442D-8800-5346A9F3F606Q38984222-719AC302-A005-4467-8B82-3422D0DFA88EQ39028665-072C513B-A6C3-4B5F-8BFC-C50D7F1725F6Q39066256-8EB0F4C0-0487-46C2-B637-0C03F6DACE5CQ39166625-92A96609-CFE5-4C14-AB5B-BC1B2A8705D8Q39553956-BAC79013-0785-4167-96CF-7A026111361DQ39957196-B4CE262E-123D-4932-B30D-B99EA6BEFFD8Q40603241-5610CEC7-A920-4951-B242-0F2C366AC600Q41897658-CC4FBF5C-1DC2-4D27-874B-1B27D734759CQ43189526-4CFB09F2-68CC-4DBB-9F2D-6214EC1D4BC5Q48882218-C8292089-5485-4E6A-BE50-075094B0F8B3Q50616556-A2657FA0-78B5-4D31-B9C4-0117882BCC47Q51013287-9A325022-4A5F-495B-8621-5B60A10FF1CBQ51706886-39054626-3394-4A1C-B766-0E979CFDCB4BQ52358331-997818CF-6E06-4C2A-9029-981891AD3603Q60403886-913113F4-51AE-4143-BF0A-888DD36C142DQ60403892-70FFDF98-BA7B-4FA7-8A01-AAF9C7B6F1C5Q64229614-F503CB30-6A1C-4D76-A97F-8A86BFF33F7DQ83323002-0A22D118-4EBB-4014-B9DE-4FF2E1909700Q83430565-F7312824-3F25-40CB-A313-BC57CC28CE51Q89791190-5A23AEB3-28F0-44B1-B395-F5F328D2A7EFQ91994351-FF773798-8F57-461B-8D69-EFC88E8991F7Q92482156-FA3A816E-C83F-4F59-AD2B-9305E41C2548
P50
description
researcher ORCID ID = 0000-0002-6814-0996
@en
wetenschapper
@nl
name
Martin E van Royen
@ast
Martin E van Royen
@en
Martin E van Royen
@es
Martin E van Royen
@nl
type
label
Martin E van Royen
@ast
Martin E van Royen
@en
Martin E van Royen
@es
Martin E van Royen
@nl
prefLabel
Martin E van Royen
@ast
Martin E van Royen
@en
Martin E van Royen
@es
Martin E van Royen
@nl
P108
P31
P496
0000-0002-6814-0996